Compare GSK plc (GSK) vs Teucrium Wheat Fund (WEAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Teucrium Wheat Fund — how do they compare? GSK plc trades at $50.37 (market cap $102.60B), while Teucrium Wheat Fund trades at $24.49. The key difference: GSK plc pays a 3.57% dividend while Teucrium Wheat Fund pays none, and Teucrium Wheat Fund is trading nearer its 52-week high, GSK plc nearer its low. Which is the better fit depends on your goals.
| GSK | WEAT | |
|---|---|---|
Market Cap | $102.60B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $61.18 | $26.00 |
52-Week Low | $38.22 | $19.88 |
Enterprise Value | $123.04B | — |
Dividend Yield | 3.57% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $50.27, down 3.62% today, with a bearish technical signal but strong fundamentals including a P/E of 16.02 and net income margin of 14.52%. Recent quarters show earnings beats, and the company announced a $2.52 billion cost-saving plan to boost its drug pipeline. Cash flow from operations remains robust at $7.74 billion for 2025.
The outlook is mixed: analyst consensus leans hold (55.18%) amid valuation concerns, but revenue growth and pipeline investments support long-term potential. Key risks include competitive pressures and regulatory uncertainty, as highlighted by recent news on vaccine policies. The stock offers a dividend yield with payments scheduled through 2026.
WEAT (Teucrium Wheat Fund) trades at $24.36, up 1.46% over the past day, with a bullish technical signal driven by moving averages. Recent performance includes a 9.9% gain over the past month and a 25% year-to-date increase as of Zacks Investment Research on July 21, 2026. The USDA reduced its 2026 U.S. wheat production outlook to 1.56 billion bushels on May 12, 2026, influencing commodity-driven volatility.
The outlook remains positive due to strong momentum and inflation hedging appeal, but risks include agricultural supply shocks and macroeconomic pressures. Investors should weigh the fund's exposure to wheat price swings against potential for continued commodity strength amid ongoing inflation concerns highlighted by ETF Trends as of June 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Teucrium Wheat Fund
WEAT is a commodity ETF that provides exposure to the price of wheat futures. It employs a laddered strategy across multiple benchmark contracts to mitigate the effects of contango and roll costs inherent in agricultural futures trading.
Read more on WEAT →
